GIDOA-03 Use of GID SVF-2 Device to Produce Autologous Adipose-Derived Stromal Vascular Fraction for Treatment of Osteoarthritis of the Knee: A Pivotal Medical Device Randomized Concurrent Controlled Study

NCT04440189

Use of GID SVF-2 Device to Produce Autologous Adipose-Derived Stromal Vascular Fraction for Treatment of Osteoarthritis of the Knee: A Pivotal Medical Device Randomized Concurrent Controlled Study

Associated Conditions

Osteoarthritis

Principal Investigator

Tariq Awan

Sponsor

The GID Group

A research study that intends to determine if an injection of stromal vascular fraction (SVF) cells derived from your own fat (adipose) will relieve pain and increase function in one of your osteoarthritic knees. The GID Group has created a single use, disposable device which can take liposuctioned fat and in approximately an hour isolate and concentrate the stromal vascular fraction cells. The device is called the GID SVF-2.